← All Can-fite Biopharma LTD filings

Can-fite Biopharma LTD Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

AMEX
CANF
Can-fite Biopharma LTD
Form 4: Can-Fite BioPharma: Motti Farbstein Reports Option Grant
Motti Farbstein, CEO, CFO, and COO of Can-Fite BioPharma Ltd., reported the acquisition of 24,000 stock options with an exercise price of $2.04.
AMEX
CANF
Can-fite Biopharma LTD
Form 4: Can-Fite BioPharma Director Acquires Options
Pnina Fishman, a Director and Chief Scientific Officer at Can-Fite BioPharma Ltd., has acquired 24,000 stock options.